Ticker: HLNE

Hamilton Lane

Finance Financials Asset Management

Price 80.62

Reco Sell Potential 54 Risk 75 Updated 2026-10-27

Official website

Forecast impact

negative

Target +16.8% target fill 85.6%

Reaction D5 pending · D10 pending market trust

Impact Potential -4 · Risk +3 valid until 2026-11-26

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

Hamilton Lane is a financial services firm specializing in private markets investment management. The company offers a range of services including investment advisory, portfolio management, and fund management. Its core products encompass private equity, private credit, and real assets. Major business segments include advisory services and investment solutions, with primary revenue sources derived from management fees and performance fees on assets under management.

Investment Profile

The stock presents a neutral investment profile, appealing to investors seeking a balance between growth and income. With a moderate dividend yield and steady revenue growth, it may attract both dividend-focused and value-oriented investors. The company's established position in the financial sector suggests a stable investment, though potential risks should be considered.

Category: Finance Sector: Financials Industry: Asset Management Investment style: Growth Horizon: Medium-term Company type: Blue Chip Company type: Market Leader

Fundamental metrics (experimental) Updated: 2026-10-24

EPS (TTM) — earnings per share for the last 12 months, $: 6.63
Revenue QoQ — quarter-over-quarter revenue growth: 42.2%
EPS surprise: 26.8%
20d volatility: 1.9%
Dividend yield: 2.8%
last ex-date: 2026-09-21

AI recommendation changes

Date	Before	After	Reason
2026-10-25	Hold	Sell	Strong fundamentals but negative momentum raises concerns.
2026-10-23	Sell	Hold	Strong fundamentals, but mixed momentum signals.
2026-10-15	Hold	Sell	Weak momentum and high risk; cautious approach advised.
2026-09-27	Sell	Hold	Strong earnings but negative momentum raises concerns.
2026-09-19	Hold	Sell	Weak momentum and high risk; hold for dividends.
2026-09-12	Buy	Hold	Strong fundamentals but negative momentum raises concerns.
2026-08-10	Hold	Buy	Strong earnings growth and positive momentum support investment.
2026-08-02	Sell	Hold	Mixed performance; cautious outlook amid market volatility.
2026-06-09	Hold	Sell	Weak fundamentals and negative momentum raise significant concerns.
2026-05-30	Sell	Hold	Weak momentum and high risk limit upside potential.
2026-05-22	Hold	Sell	Weak momentum and high risk limit upside potential.
2026-05-08	—	Hold	Weak momentum and high risk signal caution.
2026-05-08	Hold	Hold	Компания демонстрирует негативную динамику на протяжении последних месяцев, однако дивидендная доходность и стабильный EPS могут привлечь долгосрочных инвесторов.
2026-04-17	—	Hold	Компания показывает смешанные результаты, с недавним ростом за 5 дней, но значительным падением за 60 дней. Дивидендная доходность привлекательна, но высокая волатильность и риск требуют осторожности.

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-10-27	BMO Capital	Target Lowered	116 → 95	80.7556
2026-10-16	Morgan Stanley	Target Lowered	123 → 118	84.86
2026-10-13	UBS	Target Lowered	131 → 115	85.2994
2026-10-02	Goldman Sachs	Target Lowered	130 → 117	88.57
2026-10-01	Wells Fargo	Update	— → 103	88.57
2026-08-05	UBS	Target Raised	114 → 131	103.4377
2026-08-05	Oppenheimer	Target Raised	174 → 182	101.61
2026-07-21	Morgan Stanley	Target Lowered	141 → 123	84.63
2026-07-13	BMO Capital	Target Lowered	102 → 94	80.98
2026-06-30	Goldman Sachs	Target Lowered	148 → 128	75
2026-05-22	BMO Capital	Target Lowered	108 → 102	90.33
2026-05-22	Oppenheimer	Target Raised	171 → 179	89.8132
2026-05-22	Goldman Sachs	Target Raised	143 → 148	88.59
2026-04-21	Morgan Stanley	Target Lowered	159 → 141	109.8833
2026-02-20	UBS	Target Lowered	184 → 150	106.96
2026-02-04	Oppenheimer	Target Raised	220 → 230	140.51
2026-01-27	Morgan Stanley	Target Raised	154 → 159	148.17
2026-01-20	Oppenheimer	Target Raised	190 → 220	151.8718
2026-01-13	UBS	Target Raised	166 → 184	148.3
2025-12-11	UBS	Update	— → 166	132.03

News Page 1 of 1

Nothing yet